Clinical Trials Browser

Phase 4 × INDUSTRY × Carcinoma, Non-Small-Cell Lung × Clear all

NCT07279935 2026-03-19

REVIVE

Phase 4 Not yet recruiting

Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, Lung Diseases, Lung Neoplasms, Neoplasms, Neoplasms by Site, Respiratory Tract Diseases, Respiratory Tract Neoplasms, Thoracic Neoplasms

NCT03340506 2026-02-03

Dabrafenib and/or Trametinib Rollover Study

Phase 4 Recruiting

CNSDermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Glioma, Lung Neoplasms, Melanoma

NCT05144997 2025-12-17

Lorlatinib Continuation Study

Phase 4 Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT05110196 2025-12-03

Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.

Phase 4 Completed

Bronchial Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05219162 2025-09-11

GPS

Phase 4 Completed

182 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT05160922 2025-09-03

Crizotinib Continuation Clinical Study

Phase 4 Active not recruiting

LymphoidPlasma cellThoracic

Carcinoma, Non-Small-Cell Lung, Granuloma, Plasma Cell, Lymphoma, Large-Cell, Anaplastic

NCT03715205 2025-08-29

Keynote-593

Phase 4 Completed

150 enrolled 14 charts

DermatologicThoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Melanoma

NCT04078152 2024-12-20

WAVE

Phase 4 Completed

163 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT04511533 2024-04-05

Dacomitinib for Treatment of Patients in India With Metastatic Non Small Cell Lung Cancer With EGFR Activating Mutations

Phase 4 Completed

101 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT04180176 2024-01-17

PCG

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma

NCT04381494 2023-06-22

ON TRAX

Phase 4 Terminated

40 enrolled 17 charts

Carcinoma, Non-Small-Cell Lung, Pneumonia

NCT05098990 2021-10-29

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT03853551 2021-06-03

Osimertinib Study in Indian Patients

Phase 4 Completed

60 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung

NCT03444766 2020-12-04

Study of Nivolumab for Advanced Cancers in India

Phase 4 Completed

100 enrolled 12 charts

GenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms

NCT02514174 2020-03-30

Afatinib Treatment for Patients With EGFR Mutation Positive NSCLC Who Are Age 70 or Older

Phase 4 Completed

25 enrolled 13 charts

Carcinoma, Non-Small-Cell Lung

NCT03460678 2020-03-05

Randomized Comparative Study of Erlotinib and Pemetrexed in the Maintenance Treatment of Advanced Lung Cancer Patients.

Phase 4 Terminated

Carcinoma, Non-Small-Cell Lung

NCT03550482 2019-06-05

Oncoxin® and Quality of Life in Cancer Patients

Phase 4 Completed

GastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms

NCT02208843 2018-12-17

Afatinib as Second-line Therapy for Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

Phase 4 Completed

60 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT02151149 2018-09-24

ABOUND 70+

Phase 4 Completed

143 enrolled 25 charts

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

NCT02695290 2017-09-18

Afatinib in EGFR+NSCLC (Recurrent or Stage IV) - Patients With Poor Performance Status (ECOG 2 or 3)

Phase 4 Terminated

1 enrolled 3 charts

Carcinoma, Non-Small-Cell Lung

NCT03264794 2017-08-29

the Clinical Trial of Gefitinib(Non - Small Cell Lung Cancer)

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT00949910 2016-10-05

An Expanded Access Program of Tarceva (Erlotinib) in Participants With Advanced Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Completed

6,586 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00770588 2016-02-08

INFORM

Phase 4 Completed

296 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT02000531 2016-01-13

Progression Free Survival (PFS) Using Erlotinib for Non-Small-Cell Lung Cancer (NSCLC) in Chinese Population

Phase 4 Completed

45 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01646450 2015-09-09

First-line Treatment With Icotinib in Elder NSCLC EGFR Mutated Patients

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT02513355 2015-08-04

Endostar Treatment of Advanced Non-small Cell Lung Cancer Multi-center Clinical Research

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01196078 2015-07-27

A Study of Tarceva (Erlotinib) in Elderly Patients With Advanced Non-Small Cell Lung Cancer

Phase 4 Completed

114 enrolled 15 charts

Carcinoma, Non-Small-Cell Lung

NCT01926171 2015-07-15

Icotinib With Whole Brain Radiation Therapy in NSCLC Patients With Brain Metastases

Phase 4 Unknown

Carcinoma, Non-Small-Cell Lung

NCT01287754 2015-06-02

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations

Phase 4 Completed

24 enrolled 11 charts

Carcinoma, Non-Small-Cell Lung

NCT01720901 2015-05-22

Increased Dose of Icotinib in Advanced None Small Cell Lung Cancer Patients After Routine Gefitinib Therapy

Phase 4 Suspended

Carcinoma, Non-Small-Cell Lung

NCT01230710 2015-03-30

A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Following 4 Cycles of Platinum-based Chemotherapy Without Disease Progression

Phase 4 Completed

51 enrolled 10 charts

Carcinoma, Non-Small-Cell Lung

NCT01465243 2014-02-17

Dose Escalation Of Icotinib In Previously Treated Patients With Routine Dose

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT00536107 2013-10-01

Study to Assess Safety/Tolerability/Efficacy of Gefitinib Versus Docetaxel in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Phase 4 Terminated

14 enrolled 12 charts

Carcinoma, Non-Small-Cell Lung

NCT00608868 2012-09-28

SELINE

Phase 4 Completed

156 enrolled 14 charts

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT00380718 2010-11-16

Chemotherapy for Patients With Non-Small Cell Lung Cancer

Phase 4 Completed

33 enrolled 26 charts

Carcinoma, Non-Small-Cell Lung

NCT01000740 2010-05-21

A Study on the Long Term Survivals in an Expand Access Program (EAP) of Iressa

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung

NCT00099541 2009-11-23

Non-small Cell Lung Cancer Registry

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pleural Effusion, Malignant

NCT00115206 2009-04-06

Neulasta® in Subjects With Advanced Non-Small-Cell Lung Cancer (NSCLC) During Chemotherapy

Phase 4 Completed

Carcinoma, Non-Small-Cell Lung, Fever, Neutropenia